Breakthroughs Blog Old
City of Hope has so many breakthroughs in cancer, diabetes and HIV/AIDS - and so many stories - that we've tailored our blog, Breakthroughs, to provide something for every reader. Whether the breakthroughs are about medical research, treatment advances or personal triumphs, they're all connected.
CAR T Cell Therapy in Cancer Forum
November 27, 2018 | City of Hope
CAR T cell therapy is one of the most promising new approaches for treating cancer today. Come spend a day learning more about CAR T cell therapy from City of Hope’s resident experts to better understand what is now at the forefront of oncology treatment.
Renowned Cancer Researcher Named President of City of Hope National Medical Center and Physician-in-Chief of City of Hope
November 28, 2017 | City of Hope
Michael A. Caligiuri, M.D., a world-renowned cancer researcher, has been named president of City of Hope National Medical Center and physician-in-chief of City of Hope.
Get Access Now: Car t Cell Therapy for Aggressive Non-Hodgkin Lymphoma
November 17, 2017 | City of Hope
City of Hope is now offering the first-ever FDA-approved CAR T cell therapy for adult patients with certain types of large B-cell lymphoma who have not responded to or who have relapsed after at least two other kinds of treatment.
Researchers achieve remission using CAR T Cell therapy for aggressive brain tumors
February 15, 2017 | Denise Heady
City of Hope case study published in the New England Journal of Medicine reported treatment with reengineered CAR T cells dramatically improved quality of life for patient with recurrent glioblastoma.
Using CAR T cell immunotherapy to target glioblastomas
December 14, 2016 | Denise Heady
One of but a few centers in the United States offering human studies in CAR–T cell therapy, City of Hope is the only center investigating CAR T cells in injection form administered directly to brain tumors.
Clinical Trials Take CAR T Therapy to Patients Who Need It
December 14, 2016 | City of Hope
City of Hope has the clinical and scientific expertise to house the entire clinical trial process on its campus — including collecting the cells, manufacturing the lentivirus, modifying and replicating the cells and reinfusing them.
Study finds Triplex vaccine safe for use in healthy populations
December 14, 2016 | City of Hope
Data published in Blood supports ongoing phase 2 trial of Triplex in allogeneic hematopoietic stem cell transplant recipients.
Alliance Brings More Firepower to the Fight Against Cancer
December 1, 2016 | City of Hope
City of Hope joins forces with the Translational Genomics Research Institute (TGen) to accelerate the speed with which scientists and clinicians can convert research discoveries into cures.
Immunologist and diabetes chair leading new clinical trial aimed at curing type 1 diabetes
September 13, 2016 | By Letisia Marquez
Bart Roep, M.D., Ph.D., chair of City of Hope’s Department of Diabetes Immunology and an internationally recognized immunologist, is leading a clinical trial that just might lead to a cure for type 1 diabetes.
Gene therapy makes a potent weapon against against AIDS, cancer and more
August 11, 2016 | Jay Fernandez
This past year, leading-edge gene therapy has continued to take bold steps out of the laboratory and into the realm of potentially lifesaving treatments.
Load MoreBack To Top